Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT05414500
What this trial is testing

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Who this might be right for
Cutaneous T Cell LymphomaMycosis Fungoides
University of Alabama at Birmingham 10
Early research (Phase 1)Study completedNCT01026233
What this trial is testing

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Who this might be right for
Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
Seagen Inc. 52
Testing effectiveness (Phase 2)Study completedNCT02686346
What this trial is testing

Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE

Who this might be right for
Hodgkin Disease
The Lymphoma Academic Research Organisation 53
Testing effectiveness (Phase 2)Study completedNCT02497131
What this trial is testing

Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients

Who this might be right for
Lymphatic Diseases
Fondazione Italiana Linfomi - ETS 25
Early research (Phase 1)Study completedNCT01950364
What this trial is testing

Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

Who this might be right for
Hodgkin LymphomaAnaplastic Large-cell Lymphoma
Millennium Pharmaceuticals, Inc. 20
Not applicableLooking for participantsNCT06781450
What this trial is testing

Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context

Who this might be right for
Primary Mediastinal B Cell Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 50
Testing effectiveness (Phase 2)Looking for participantsNCT06377566
What this trial is testing

BV-AVD in People With Bulky Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT03113500
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

Who this might be right for
Adult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-Positive+8 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)UnknownNCT05243693
What this trial is testing

Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Classical Hodgkin Lymphoma
National Cancer Center, Korea 30
Testing effectiveness (Phase 2)Study completedNCT01396070
What this trial is testing

Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Cutaneous LymphomaCutaneous T-cell Lymphoma (CTCL)+2 more
Youn Kim 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT02758717
What this trial is testing

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage IB Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin Lymphoma+8 more
Academic and Community Cancer Research United 46
Not applicableStudy completedNCT02139592
What this trial is testing

Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"

Who this might be right for
Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma
Takeda 292
Testing effectiveness (Phase 2)Study completedNCT03222492
What this trial is testing

Brentuximab Vedotin for Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerodermadcSSc
National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableStudy completedNCT01578967
What this trial is testing

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT02227199
What this trial is testing

Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
University of Washington 45
Testing effectiveness (Phase 2)Study completedNCT04609566
What this trial is testing

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Seagen, a wholly owned subsidiary of Pfizer 161
Testing effectiveness (Phase 2)Study completedNCT01492088
What this trial is testing

Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaRelapsed or Refractory Anaplastic Large-cell Lymphoma
Millennium Pharmaceuticals, Inc. 36
Early research (Phase 1)Study completedNCT01902160
What this trial is testing

Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Recurrent Adult Hodgkin Lymphoma
National Cancer Institute (NCI) 3
Not applicableWithdrawnNCT01671813
What this trial is testing

Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT02429375
What this trial is testing

Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 7
Next Page